iifl-logo

Bafna Pharmaceuticals Ltd Share Price Live

84.03
(5.00%)
Jun 30, 2025|02:36:20 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open80.03
  • Day's High84.03
  • 52 Wk High96
  • Prev. Close80.03
  • Day's Low80
  • 52 Wk Low 69
  • Turnover (lac)8.34
  • P/E29.37
  • Face Value10
  • Book Value35.93
  • EPS2.66
  • Mkt. Cap (Cr.)198.78
  • Div. Yield0
View All Historical Data
No Records Found

Bafna Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

80.03

Prev. Close

80.03

Turnover(Lac.)

8.34

Day's High

84.03

Day's Low

80

52 Week's High

96

52 Week's Low

69

Book Value

35.93

Face Value

10

Mkt Cap (₹ Cr.)

198.78

P/E

29.37

EPS

2.66

Divi. Yield

0

Bafna Pharmaceuticals Ltd Corporate Action

3 Sep 2024

12:00 AM

AGM

Announcement Date: 03 Sep, 2024

arrow

23 Jun 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Bafna Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bafna Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

30 Jun, 2025|06:24 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 75.00%

Foreign: 0.00%

Indian: 75.00%

Non-Promoter- 8.53%

Institutions: 8.53%

Non-Institutions: 16.46%

Custodian: 0.00%

Share Price

Bafna Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

23.66

23.66

23.66

23.66

Preference Capital

0

0

0

0

Reserves

57.18

49.8

38.31

33.11

Net Worth

80.84

73.46

61.97

56.77

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

85.14

71.21

42.47

77.2

yoy growth (%)

19.54

67.68

-44.98

18.85

Raw materials

-39.28

-36.52

-19.98

-38.28

As % of sales

46.13

51.28

47.05

49.58

Employee costs

-14.5

-11.98

-10.25

-7.47

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

7.3

5.82

-1.87

-14.27

Depreciation

-5.49

-4.47

-3.26

-3.64

Tax paid

0

0

0

-2.17

Working capital

-0.75

16.58

6.23

-27.03

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

19.54

67.68

-44.98

18.85

Op profit growth

11.6

738.01

-124.32

-3.16

EBIT growth

23.33

-468.5

-76.13

-6.25

Net profit growth

-11.59

-123.11

53.2

-10.93

View Ratios
Particulars (Rupees in Crores.)Mar-2019Mar-2018Mar-2017Mar-2016Mar-2015

Gross Sales

43.36

47.17

64.96

85.32

97.67

Excise Duty

0

0

0

0

0

Net Sales

43.36

47.17

64.96

85.32

97.67

Other Operating Income

0

0

0

0

41.11

Other Income

1.66

31.33

1.14

1.98

4.9

Bafna Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,687.6

94.574,05,007.742,000.460.957,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,658

80.011,76,747.656670.452,536561.08

Cipla Ltd

CIPLA

1,502.4

25.221,21,378.291,485.41.064,254.47397.41

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,341.4

59.41,13,184.614740.962,385224.33

Dr Reddys Laboratories Ltd

DRREDDY

1,301

20.31,08,591.611,200.70.615,546.3345.76

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Bafna Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Whole Time Director

Shanmugam Hemalatha

Non-Exec & Non-Independent Dir

Akilapriya Chandrashekar Raju

Non-Exec. & Independent Dir.

Ravichandran Chitra

Non Executive Director

Upendar Mekala Reddy

Whole-time Director

Vinayak Dinesh Dendukuri

Company Sec. & Compli. Officer

A Mohanachandran

Additional Director

Navin Kumar

Registered Office

Bafna Towers New No 68,

Old No 299 Thambu Chetty St,

Tamil Nadu - 600001

Tel: 91-44-25267517/25270992/4267755

Website: http://www.bafnapharma.com

Email: cs@bafnapharma.com; info@bafnapharma.com

Registrar Office

Subramanian Building,

V Floor, 1 Club House Road,

Chennai - 600 002

Tel: 91-044-28460390 (5 L

Website: www.cameoindia.com

Email: cameo@cameoindia.com

Summary

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing p...
Read More

Company FAQs

What is the Bafna Pharmaceuticals Ltd share price today?

The Bafna Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹84.03 today.

What is the Market Cap of Bafna Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bafna Pharmaceuticals Ltd is ₹198.78 Cr. as of 30 Jun ‘25

What is the PE and PB ratio of Bafna Pharmaceuticals Ltd?

The PE and PB ratios of Bafna Pharmaceuticals Ltd is 29.37 and 2.18 as of 30 Jun ‘25

What is the 52 Week High and Low of Bafna Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Bafna Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bafna Pharmaceuticals Ltd is ₹69 and ₹96 as of 30 Jun ‘25

What is the CAGR of Bafna Pharmaceuticals Ltd?

Bafna Pharmaceuticals Ltd's CAGR for 5 Years at 29.00%, 3 Years at -12.72%, 1 Year at 1.00%, 6 Month at 0.04%, 3 Month at 4.85% and 1 Month at 5.65%.

What is the shareholding pattern of Bafna Pharmaceuticals Ltd?

The shareholding pattern of Bafna Pharmaceuticals Ltd is as follows:
Promoters - 75.00 %
Institutions - 8.53 %
Public - 16.47 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.